Victory Capital Management Inc. Sells 8,908 Shares of Danaher Corporation $DHR

Victory Capital Management Inc. reduced its stake in shares of Danaher Corporation (NYSE:DHR) by 4.2% in the third quarter, Holdings Channel reports. The firm owned 203,242 shares of the conglomerate’s stock after selling 8,908 shares during the period. Victory Capital Management Inc.’s holdings in Danaher were worth $40,295,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. WFA of San Diego LLC bought a new position in Danaher in the 2nd quarter worth about $26,000. Howard Hughes Medical Institute purchased a new position in shares of Danaher during the second quarter worth approximately $27,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher during the third quarter valued at approximately $27,000. TruNorth Capital Management LLC purchased a new stake in shares of Danaher in the third quarter valued at approximately $28,000. Finally, Tripletail Wealth Management LLC purchased a new stake in shares of Danaher in the third quarter valued at approximately $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of Danaher stock opened at $195.60 on Friday. The company has a market capitalization of $138.32 billion, a PE ratio of 38.81, a P/E/G ratio of 2.64 and a beta of 0.93. The company has a 50-day simple moving average of $222.53 and a two-hundred day simple moving average of $215.95. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. Danaher’s revenue was up 4.6% compared to the same quarter last year. During the same period last year, the firm earned $2.14 earnings per share. Research analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 annualized dividend and a yield of 0.8%. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is presently 25.40%.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on DHR shares. Evercore restated an “outperform” rating and set a $254.00 price objective on shares of Danaher in a report on Wednesday, January 28th. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Wells Fargo & Company raised their price target on Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Morgan Stanley started coverage on Danaher in a report on Monday, December 1st. They issued an “overweight” rating and a $270.00 price objective for the company. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $253.86.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.